Department of Surgery, University of Michigan Health System, Ann Arbor, MI, USA.
Crit Care Med. 2010 Apr;38(4 Suppl):e74-90. doi: 10.1097/CCM.0b013e3181cc5373.
Severe respiratory failure (including acute lung injury and acute respiratory distress syndrome) caused by 2009 H1N1 influenza infection has been reported worldwide. Refractory hypoxemia is a common finding in these patients and can be challenging to manage. This review focuses on nonventilatory strategies in the advanced treatment of severe respiratory failure and refractory hypoxemia such as that seen in patients with severe acute respiratory distress syndrome attributable to 2009 H1N1 influenza. Specific modalities covered include conservative fluid management, prone positioning, inhaled nitric oxide, inhaled vasodilatory prostaglandins, and extracorporeal membrane oxygenation and life support. Pharmacologic strategies (including steroids) investigated for the treatment of severe respiratory failure are also reviewed.
世界范围内有报道称,2009 年 H1N1 流感感染可导致严重呼吸衰竭(包括急性肺损伤和急性呼吸窘迫综合征)。这些患者常存在难治性低氧血症,且治疗颇具挑战。本综述重点关注严重呼吸衰竭和难治性低氧血症(如严重急性呼吸窘迫综合征患者)的高级治疗中的非通气策略,这些患者与 2009 年 H1N1 流感相关。具体涵盖的方法包括保守液体管理、俯卧位通气、吸入性一氧化氮、吸入性血管扩张性前列腺素以及体外膜氧合和生命支持。还对治疗严重呼吸衰竭的药物治疗策略(包括皮质类固醇)进行了综述。